Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria

Hutchinson-Gilford progeria syndrome (HGPS) is caused by the accumulation of a farnesylated form of prelamin A (progerin). Previously, we showed that blocking protein farnesylation with a farnesyltransferase inhibitor (FTI) ameliorates the disease phenotypes in mouse model of HGPS (Lmna(HG/+)). Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shao H., Chang, Sandy Y., Andres, Douglas A., Spielmann, H. Peter, Young, Stephen G., Fong, Loren G.
Formato: Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803242/
https://www.ncbi.nlm.nih.gov/pubmed/19965595
http://dx.doi.org/10.1194/jlr.M002808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803242/
https://www.ncbi.nlm.nih.gov/pubmed/19965595
http://dx.doi.org/10.1194/jlr.M002808

Ejemplares similares